Jefferies Raises Price Target on Chemours (CC) to $25
- S&P 500, Nasdaq set records as tech, banks lead
- Texas Instruments (TXN) Tops Q4 EPS by 20c, Issues Solid Q1 Outlook
- Intuitive Surgical (ISRG) Tops Q4 EPS by 10c; $2B Accelerated Share Repurchase
- Seagate Technology (STX) Tops Q2 EPS by 30c
- After-Hours Stock Movers 01/24: (BOBE) (STX) (WDC) Higher; (NEWT) (MRCY) (CA) Lower (more...)
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Jefferies reiterated a Hold rating on Chemours (NYSE: CC), and raised the price target to $25.00 (from $17.00). Chemours continues to execute and should generate > $150m of incremental EBITDA from Opteon and Altamira. Ongoing cost reductions will continue to contribute to margins. The company has removed $160m YTD of their $200m target and expects to remove an additional $150m of mostly fixed costs in 2017.
Analyst Laurence Alexander commented, "Divestitures and restructuring are addressing leverage concerns, and the mix of a faster ramp in Opteon and improving TiO2 margins has reset valuations. Headwinds from fluoropolymers and litigation should be muted by cyclical leverage to TiO2 (and customer restocking near-term), Opteon and cost controls. The Bartlett appeal decision in 1H17 will be a key litmus test providing increased clarity on the PFOA liability."
Shares of Chemours closed at $22.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mercury Computer (MRCY) PT Raised to $30 at Jefferies Following 2Q Report
- CBS Corp. (CBS): Raising PT On Higher Retransmission Fees - Needham
- Facebook (FB) Q4 Estimates, PT Raised At Jefferies
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!